Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates

Spruce Biosciences, Inc. (SPRB) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of$ 0.33. This compares to loss of $0.32 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 33.33%. A quarter ago, it was expected that this company would post a loss of$ 0.32 per share when it actually produced a loss of $0.28, delivering a surprise of 12.50%. Over the last four quarters, the company h ...